|
||||||||||||||||
HUM-MOLGEN -> Events -> Meetings and Conferences | ||||||||||||||||
Anti-Cancer Drug Discovery and Development | ||||||||||||||||
April 29, 2002 | ||||||||||||||||
Strategic Research Institute, Princeton Marriott 06/17/2002 - 06/19/2002 New Oncology Business Development & Licensing Panel: The Oncology Licensing & Deal-making Climate for 2002-03 Topics Include: -Cyclin Dependent Kinases -Tie-2 Kinase -EGFRs -Epothilones -Antimitotic Agents -Novel Taxanes -Proteasome Inhibition -Ubiquitin Ligases -Vascular Targeting -Ribozymes -COX-2 Inhibitors -Thalidomide -Telomerase Inhibition -Antibodies |
||||||||||||||||
Organized by: | Strategic Research Institute | |||||||||||||||
Invited Speakers: | n/a | |||||||||||||||
Deadline for Abstracts: | na | |||||||||||||||
Registration: | n/a | |||||||||||||||
E-mail: | ckahan-radhuber@srinstitute.com | |||||||||||||||
Posted by: | Cheryl Kahan-Radhuber | |||||||||||||||
Host: | 12.3.58.3 | |||||||||||||||
|
||||||||||||||||
Generated by meetings and positions 5.0 by Kai Garlipp |